Olga Bornachea

Olga Bornachea

Auto-generated profile, based on publicly available information

Olga Bornachea

Molecular Oncology Unit, CIEMAT, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2012 in Scientific Reports
Verified
Journal Article
Open access
OBOlga Bornachea
Olga Bornachea
MSMirentxu Santos
Mirentxu Santos
AMAna Belén Martínez-Cruz
Ana Belén Martínez-Cruz
RGRamon Garcia-Escudero
Ramon Garcia-Escudero
MDMarta Dueñas
Marta Dueñas
JESÚS M ParamioJESÚS M Paramio
JESÚS M Paramio
Missense mutations in TP53 gene promote metastasis in human tumours. However, little is known about the complete loss of function of p53 in tumour metastasis. Here we show that squamous cell carcinomas generated by the specific ablation of Trp53 gene in mouse epidermis are highly metastatic. Biochemical and genome-wide mRNA and miRNA analyses demonstrated that metastases are associated with the early induction of epithelial-mesenchymal transition (EMT) and deregulated miRNA expression in primary tumours. Increased expression of miR-21 was observed in undifferentiated, prometastatic mouse tumours and in human tumours characterized by p53 mutations and distant metastasis. The augmented expression of miR-21, mediated by active mTOR and Stat3 signalling, conferred increased invasive properties to mouse keratinocytes in vitro and in vivo, whereas blockade of miR-21 in a metastatic spindle cell line inhibits metastasis development. Collectively these data identify novel molecular mechanisms leading to metastasis in vivo originated by p53 loss in epithelia.

1 July 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
OBOlga Bornachea
Olga Bornachea
FLFernando F. López-Calderón
Fernando F. López-Calderón
MDMarta Dueñas
Marta Dueñas
CSCarmen Segrelles
Carmen Segrelles
CLCorina Lorz
Corina Lorz
JESÚS M ParamioJESÚS M Paramio
JESÚS M Paramio
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Olga Bornachea1, Fernando F. López-Calderón1, 2, Marta Dueñas1, 2, Carmen Segrelles1, 2, Corina Lorz1, 2, Cristian Suárez-Cabrera1, 2, María Marañón1, Beatriz Paradela-Dobarro1, Mirentxu Santos1, 2, Jesús M. Paramio1, 2 1Molecular Oncology Unit, CIEMAT, 28040 Madrid, Spain 2Molecular Oncology, Institute of Biomedical Investigation University Hospital, 28041 Madrid, Spain Correspondence to: Mirentxu Santos, e-mail: mirentxu.santos@ciemat.es Jesús M. Paramio, e-mail: jesusm.paramio@ciemat.es Keywords: p63, p53, metastasis, miRNA, skin Received: May 05, 2015 Accepted: June 19, 2015 Published: July 01, 2015 ABSTRACT The TP63 gene codes for two major isoform types, TAp63 and ΔNp63, with probable opposite roles in tumorigenesis. The ΔNp63α protein is frequently amplified and overexpressed in different epithelial tumors. Accordingly, it has been considered a potential oncogene. Nonetheless, a possible metastatic suppressor activity has also been suggested based on the experimental observation that its expression is reduced or even absent in advanced invasive tumors. Such metastatic suppressor activities are often related to tumors bearing point mutated TP53 gene. However, its potential roles in TP53-deficient tumors are poorly characterized. Here we show that in spontaneous tumors, induced by the epidermal-specific Trp53 ablation, the reduction of ΔNp63 expression is an early event, whereas it is re-expressed in the lung metastatic lesions. Using knock down and ectopic expression approaches, we show that ΔNp63 expression opposes the epithelial-mesenchymal transition and reduces the metastatic potential of the cells. This process occurs through the modulation of ΔNp63-dependent downstream targets (including transcription factors and microRNAs) likely to play metastatic roles. Further, ΔNp63 also favors the expression of factors involved in iPS reprogramming, thus suggesting that it can also modulate specific stem cell traits in mouse epidermal tumor cells. Overall, our data assign antimetastatic roles to ΔNp63 in the context of p53 deficiency and epidermis.